BRUKER CORPORATION Deferred Revenue Recognized
BRUKER CORPORATION (BRKR) reported Deferred Revenue Recognized of $294.00 million for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-05
- BRUKER CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2021-03-31 was $121.40M, a 58.28% increase year-over-year.
- BRUKER CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2020-03-31 was $76.70M, a 1.99% increase year-over-year.
- BRUKER CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $75.20M.
- BRUKER CORPORATION contract with customer, liability, revenue recognized for fiscal 2024 was $389.50M, a 11.73% increase from fiscal 2023.
- BRUKER CORPORATION contract with customer, liability, revenue recognized for fiscal 2023 was $348.60M, a 1.66% increase from fiscal 2022.
- BRUKER CORPORATION contract with customer, liability, revenue recognized for fiscal 2022 was $342.90M, a 18.49% increase from fiscal 2021.
- BRUKER CORPORATION contract with customer, liability, revenue recognized for fiscal 2021 was $289.40M.
| Period end | Contract with Customer, Liability, Revenue Recognized | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $294.00M 10-Q · filed 2026-08-05 | $186.50M 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | $389.50M 10-K · filed 2026-02-27 | $143.00M 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | $348.60M 10-K · filed 2025-03-03 | $130.40M 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | $342.90M 10-K · filed 2024-02-29 | $150.40M 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | $289.40M 10-K · filed 2023-03-01 | $126.00M 10-Q · filed 2022-05-06 | ||||
| 2021-09-30 | $250.50M 10-Q · filed 2021-11-05 | |||||
| 2021-06-30 | $195.40M 10-Q · filed 2021-08-05 | |||||
| 2021-03-31 | $121.40M 10-Q · filed 2021-05-10 | |||||
| 2020-12-31 | $270.00M 10-K · filed 2022-02-28 | |||||
| 2020-09-30 | $180.10M 10-Q · filed 2020-11-06 | |||||
| 2020-06-30 | $119.20M 10-Q · filed 2020-08-07 | |||||
| 2020-03-31 | $76.70M 10-Q · filed 2020-05-11 | |||||
| 2019-12-31 | $184.80M 10-K · filed 2021-03-01 | |||||
| 2019-09-30 | $165.00M 10-Q · filed 2019-11-04 | |||||
| 2019-06-30 | $137.00M 10-Q · filed 2019-08-09 | |||||
| 2019-03-31 | $75.20M 10-Q · filed 2019-05-08 | |||||
| 2018-12-31 | $186.10M 10-K · filed 2020-03-27 | $171.00M 10-K · filed 2019-03-01 | ||||
| 2018-09-30 | $145.80M 10-Q · filed 2018-11-09 | |||||
| 2018-06-30 | $100.70M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |